Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)
Abstract Cancer survivors receiving doxorubicin may experience left ventricular ejection fraction (LVEF) decline during and following treatment; however, explanations for variations in decline beyond dosage differences, such as those related to socioeconomic status (SES), have not been fully examine...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-02-01
|
| Serija: | Cardio-Oncology |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s40959-025-00311-y |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
